Monday, February 13, 2012
  • Diabetes Home>
  • News>
  • FDA wants Januvia, Janumet label updated for pancreatitis risk

FDA wants Januvia, Janumet label updated for pancreatitis risk

(Reuters) UPDATED 2009-09-29
The U.S. Food and Drug Administration (FDA) is asking Januvia and Janumet's drugmaker to add information about the risk of pancreatitis to the medications' labels. The FDA says they have received reports of 88 cases of acute pancreatitis since the drug (sitagliptin) was approved in 2006. Experts point out that diabetics already have an increased risk of pancreatitis, regardless of which treatment they are on, and they urge patients to talk to their doctor if they experience nausea, persistent abdominal pain, and vomiting.  Read full story >
See all Diabetes News

People who read this also read...